Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 86

Related Citations for PubMed (Select 23611915)

1.

Neuraxial block, death and serious cardiovascular morbidity in the POISE trial.

Leslie K, Myles P, Devereaux P, Williamson E, Rao-Melancini P, Forbes A, Xu S, Foex P, Pogue J, Arrieta M, Bryson G, Paul J, Paech M, Merchant R, Choi P, Badner N, Peyton P, Sear J, Yang H.

Br J Anaesth. 2013 Sep;111(3):382-90. doi: 10.1093/bja/aet120. Epub 2013 Apr 23.

2.

Nitrous oxide and serious morbidity and mortality in the POISE trial.

Leslie K, Myles P, Devereaux PJ, Forbes A, Rao-Melancini P, Williamson E, Xu S, Foex P, Pogue J, Arrieta M, Bryson GL, Paul J, Paech MJ, Merchant RN, Choi PT, Badner N, Peyton P, Sear JW, Yang H.

Anesth Analg. 2013 May;116(5):1034-40. doi: 10.1213/ANE.0b013e318270014a. Epub 2013 Jan 21. Erratum in: Anesth Analg. 2013 Aug;117(2):522.

PMID:
23337413
3.

Neuraxial anaesthesia for lower-limb revascularization.

Barbosa FT, Jucá MJ, Castro AA, Cavalcante JC.

Cochrane Database Syst Rev. 2013 Jul 29;7:CD007083. doi: 10.1002/14651858.CD007083.pub3. Review.

PMID:
23897485
4.

Neuraxial anaesthesia for lower-limb revascularization.

Barbosa FT, Cavalcante JC, Jucá MJ, Castro AA.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD007083. doi: 10.1002/14651858.CD007083.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;7:CD007083.

PMID:
20091615
5.

Neuraxial block, death, and serious cardiovascular morbidity in the POISE trial.

Nagele P.

Br J Anaesth. 2014 Feb;112(2):392. doi: 10.1093/bja/aet573. No abstract available.

6.

Neuraxial block, death and serious cardiovascular morbidity in patients in the POISE trial: propensities, probabilities, and possibilities.

Cook TM, Columb MO.

Br J Anaesth. 2013 Sep;111(3):327-31. doi: 10.1093/bja/aet163. No abstract available.

7.

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators.

Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G.

N Engl J Med. 2000 Jan 20;342(3):145-53. Erratum in: 2000 May 4;342(18):1376. N Engl J Med 2000 Mar 9;342(10):748.

8.

Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: Insights from the Survival and Ventricular Enlargement Trial.

Kenchaiah S, Davis BR, Braunwald E, Rouleau JL, Dagenais GR, Sussex B, Steingart RM, Brown EJ Jr, Lamas GA, Gordon D, Bernstein V, Pfeffer MA; Survival and Ventricular Enlargement Trial.

Am Heart J. 2004 Aug;148(2):356-64.

PMID:
15309009
9.

Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block: the Swiss Beta Blocker in Spinal Anesthesia (BBSA) study: a double-blinded, placebo-controlled, multicenter trial with 1-year follow-up.

Zaugg M, Bestmann L, Wacker J, Lucchinetti E, Boltres A, Schulz C, Hersberger M, Kälin G, Furrer L, Hofer C, Blumenthal S, Müller A, Zollinger A, Spahn DR, Borgeat A.

Anesthesiology. 2007 Jul;107(1):33-44.

PMID:
17585213
10.

A comparison of neuraxial block versus general anesthesia for elective total hip replacement: a meta-analysis.

Mauermann WJ, Shilling AM, Zuo Z.

Anesth Analg. 2006 Oct;103(4):1018-25.

PMID:
17000823
11.

Long-term outcomes of left bundle branch block in high-risk survivors of acute myocardial infarction: the VALIANT experience.

Stephenson K, Skali H, McMurray JJ, Velazquez EJ, Aylward PG, Kober L, Van de Werf F, White HD, Pieper KS, Califf RM, Solomon SD, Pfeffer MA.

Heart Rhythm. 2007 Mar;4(3):308-13. Epub 2006 Nov 29.

PMID:
17341394
12.

Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials.

Rodgers A, Walker N, Schug S, McKee A, Kehlet H, van Zundert A, Sage D, Futter M, Saville G, Clark T, MacMahon S.

BMJ. 2000 Dec 16;321(7275):1493. Review.

13.
14.

A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.

Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE, Hennekens CH, Buring JE.

N Engl J Med. 2005 Mar 31;352(13):1293-304. Epub 2005 Mar 7.

15.

General anaesthesia is associated with adverse cardiac outcome after endovascular aneurysm repair.

Bakker EJ, van de Luijtgaarden KM, van Lier F, Valentijn TM, Hoeks SE, Klimek M, Verhagen HJ, Stolker RJ.

Eur J Vasc Endovasc Surg. 2012 Aug;44(2):121-5. doi: 10.1016/j.ejvs.2012.04.028. Epub 2012 May 22.

16.
17.

Cardiac arrest during neuraxial anesthesia: frequency and predisposing factors associated with survival.

Kopp SL, Horlocker TT, Warner ME, Hebl JR, Vachon CA, Schroeder DR, Gould AB Jr, Sprung J.

Anesth Analg. 2005 Mar;100(3):855-65, table of contents.

PMID:
15728079
18.

Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study.

Hansson L, Hedner T, Lund-Johansen P, Kjeldsen SE, Lindholm LH, Syvertsen JO, Lanke J, de Faire U, Dahlöf B, Karlberg BE.

Lancet. 2000 Jul 29;356(9227):359-65.

PMID:
10972367
19.
20.

Rationale, design, and organization of the PeriOperative ISchemic Evaluation (POISE) trial: a randomized controlled trial of metoprolol versus placebo in patients undergoing noncardiac surgery.

POISE Trial Investigators, Devereaux PJ, Yang H, Guyatt GH, Leslie K, Villar JC, Monteri VM, Choi P, Giles JW, Yusuf S.

Am Heart J. 2006 Aug;152(2):223-30.

PMID:
16875901
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk